Recruiting PHASE2 INTERVENTIONAL 2-arm
NCT07362810
G-CSF Combined With IL-11 on Hematopoietic Reconstitution After Autologous Hematopoietic Stem Cell Transplantation
The Impact of G-CSF Combined With IL-11 on Hematopoietic Reconstitution After Autologous Hematopoietic Stem Cell Transplantation
Sponsor: Fudan University
Conditions
Hemato-oncologic Patients Hematopoetic Stem Cell Transplantation Mobilization of Hematopoietic Stem Cells (HSC) to Peripheral Blood (PB)
Interventions
G-CSF Granulocyte-Colony Stimulating Factor G-CSF+IL-11
Updated 1 time since 2026 Last updated: Jan 22, 2026 Started: Jan 1, 2026 Primary completion: Dec 30, 2026 Completion: Dec 30, 2026
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
This PHASE2 trial investigates Hemato-oncologic Patients and Hematopoetic Stem Cell Transplantation and is currently actively recruiting participants. Fudan University leads this study, which shows 1 recorded version since 2026 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
1 version recorded Recruiting — PHASE2
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Fudan University
Data source: Fudan University
For direct contact, visit the study record on ClinicalTrials.gov .